Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit
NCT ID: NCT00808691
Last Updated: 2015-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
124 participants
OBSERVATIONAL
2007-09-30
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In clinical practice, the oxidative stress is related to circulatory shock, sepsis, acute lung injury, and acute respiratory distress syndrome. This study tries to investigate the relation between oxidative stress and microcirculation. Furthermore, the investigators will try to investigate the correlation between the severity of oxidative stress and microcirculatory dysfunction and the severity of disease and prognosis. The investigators hope this study will help them to figure out the picture of disease progression of patients. It may conduct further study to modulate the oxidative stress, to improve the microcirculatory function, and finally to improve the outcome of patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit
NCT00745888
The Blood Pressure Analysis on Critically Ill Patients
NCT03827369
Multiple Biomarkers in ICU Sepsis Patients
NCT03802136
Sepsis in ICU:Causes and Outcomes of Sepsis in Diabetics Versus Non Diabetics in Assiut University Hospital
NCT04015752
Assessment of Microcirculation Alteration With Both Sublingual Microcirculation and Near-infrared Spectroscopy on ARDS
NCT05180409
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients with sepsis
Critical care
Standard care for each group of patients
2
Patient admitted for postoperative care
Critical care
Standard care for each group of patients
3
Patients with ARDS
Critical care
Standard care for each group of patients
4
Patients with ARF
Critical care
Standard care for each group of patients
5
Patients who receive liver support treatment
Critical care
Standard care for each group of patients
6
Patients wiht brain death
Critical care
Standard care for each group of patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Critical care
Standard care for each group of patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Related diagnosis made within 24h
* Group 1 - Sepsis
* Group 2 - Postoperative care
* Group 3 - ARDS
* Group 4 - Renal failure
* Group 5 - Liver failure
* Group 6 - Brain death
Exclusion Criteria
* Related diagnosis made longer than 24h
* Patients who have received antioxidants within 24h
* Patients who have received hyperbaric oxygen therapy
* Patients who have a hemoglobin value less than 9 g/dl
* Patients who have received NO
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yu-Chang Yeh, M.D
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200707012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.